TITLE

Choosing the right memory T cell for HIV

AUTHOR(S)
Franchini, Genoveffa
PUB. DATE
March 2009
SOURCE
Nature Medicine;Mar2009, Vol. 15 Issue 3, p244
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the experimental simian immunodeficiency virus (SIV) vaccine for the mucosa of vagina and rectum to prevent HIV. It notes that researchers based their vaccine on infectious replication-competent rhesus macaque cytomegalovirus after observing that the vaccines protect macaques from mucosal acquisition of SIV. Researchers conclude that expression of HIV antigens at mucosal sites can protect CD+ effector memory T (TC,M) cells from SIV acquisition.
ACCESSION #
36818279

 

Related Articles

  • Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus. Dey, Ayan; Molodecky, Natalie A.; Verma, Harish; Sharma, Prashant; Yang, Jae Seung; Saletti, Giulietta; Ahmad, Mohammad; Bahl, Sunil K.; Wierzba, Thomas F.; Nandy, Ranjan K.; Deshpande, Jagadish M.; Sutter, Roland W.; Czerkinsky, Cecil // PLoS ONE;1/5/2016, Vol. 11 Issue 1, p1 

    Background: The “gold standard” for assessing mucosal immunity after vaccination with poliovirus vaccines consists in measuring virus excretion in stool after challenge with oral poliovirus vaccine (OPV). This testing is time and resource intensive, and development of alternative...

  • Mucosal immunity: Some historical perspective on host-pathogen interactions and implications for mucosal vaccines*. Ogra, Pearay L // Immunology & Cell Biology;Feb2003, Vol. 81 Issue 1, p23 

    Examines some of the historical aspects of the evolution of the concepts of mucosal immunity. Implications to the development of vaccines specifically designed to capitalize on mucosal immunology; Role of mucosal immunity in the modulation of mammalian immune responses; Use as delivery sites...

  • IL-2, IL-7 and IL-15 as Immuno-Modulators During SIV/HIV Vaccination and Treatment. Leone, Amanda; Picker, Louis J.; Sodora, Donald L. // Current HIV Research;Jan2009, Vol. 7 Issue 1, p83 

    While highly active antiretroviral therapy (HAART) regimens have proven to be effective in controlling active HIV replication, complete recovery of CD4+ T cells does not always occur, even among patients with high level virologic control. Recent advances in understanding the biology of T cell...

  • Cytotoxic T-Lymphocyte Escape Monitoring in Simian Immunodeficiency Virus Vaccine Challenge Studies. O'Connor, David H.; Allen, Todd M.; Watkins, David I. // DNA & Cell Biology;Sep2002, Vol. 21 Issue 9, p659 

    Several vaccine studies have ameliorated disease progression in simian–human immunodeficiency virus (SHIV) infections. The successes of these vaccines have been largely attributed to protective effects of cytotoxic T-lymphocyte (CTL) responses, although the precise correlates of immune...

  • Human clinical testing of systemic PMPA begins.  // AIDS Patient Care & STDs;Feb1997, Vol. 11 Issue 1, p37 

    Reports on the use of PMPA which demonstrates activity against simian immunodeficiency virus infection in preclinical testing. Planning of randomized, double-blind, placebo-controlled human study; Assessment of PMPA's safety when administered by intravenous infusion.

  • rectovaginal.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1984 

    A definition of the term "rectovaginal," which refers to the rectum and vagina, is presented.

  • The history of vaccination against cytomegalovirus. Plotkin, Stanley // Medical Microbiology & Immunology;Jun2015, Vol. 204 Issue 3, p247 

    Cytomegalovirus vaccine development started in the 1970s with attenuated strains. In the 1980s, one of the strains was shown to be safe and effective in renal transplant patients. Then, attention switched to glycoprotein gB, which was shown to give moderate but transient protection against...

  • Altered Response Hierarchy and Increased T-Cell Breadth upon HIV-1 Conserved Element DNA Vaccination in Macaques. Kulkarni, Viraj; Valentin, Antonio; Rosati, Margherita; Alicea, Candido; Singh, Ashish K.; Jalah, Rashmi; Broderick, Kate E.; Sardesai, Niranjan Y.; Le Gall, Sylvie; Mothe, Beatriz; Brander, Christian; Rolland, Morgane; Mullins, James I.; Pavlakis, George N.; Felber, Barbara K. // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    HIV sequence diversity and potential decoy epitopes are hurdles in the development of an effective AIDS vaccine. A DNA vaccine candidate comprising of highly conserved p24gag elements (CE) induced robust immunity in all 10 vaccinated macaques, whereas full-length gag DNA vaccination elicited...

  • Experimental vaccine has potential to reduce maternal CMV transmission.  // Infectious Diseases in Children;May2009, Vol. 22 Issue 5, p20 

    The article reports on a phase-2, double blind, placebo-controlled trial which showed that participants who received the experimental cytomegalovirus vaccine containing glycoprotein B and MF59, a squalene-in-water emulsion adjuvant, were significantly less likely to experience an infection...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics